Allergan Inc. (NYSE: AGN) has completed its $370 million cash acquisition of Esprit Pharma Inc., an East Brunswick, N.J.
Allergan Inc. (NYSE: AGN) has completed its $370 million cash acquisition of Esprit Pharma Inc., an East Brunswick, N.J.
Copyright PEI Media
Not for publication, email or dissemination